The True Medicine (Volume 4) (The Other Voice in Early Modern Europe: The Toronto Series)

(2)
The True Medicine (Volume 4) (The Other Voice in Early Modern Europe: The Toronto Series) image
ISBN-10:

0772720673

ISBN-13:

9780772720672

Edition: Critical ed.
Released: Mar 01, 2010
Publisher: Iter Press
Format: Paperback, 267 pages

Description:

One of the first printed medical texts to be attributed to a female author, "The True Medicine" (1587) is radically innovative in its rejection of contemporary medical theory for a more pro-feminist physiology and cosmology. With unprecedented clarity and care, Gianna Pomata brings an important text in the history of scientific authorship to the attention of modern-day readers.

Best prices to buy, sell, or rent ISBN 9780772720672




Frequently Asked Questions about The True Medicine (Volume 4) (The Other Voice in Early Modern Europe: The Toronto Series)

You can buy the The True Medicine (Volume 4) (The Other Voice in Early Modern Europe: The Toronto Series) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $24.78 on Amazon and is available from 12 sellers at the moment.

If you’re interested in selling back the The True Medicine (Volume 4) (The Other Voice in Early Modern Europe: The Toronto Series) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the The True Medicine (Volume 4) (The Other Voice in Early Modern Europe: The Toronto Series) book, the best buyback offer comes from and is $ for the book in good condition.

The The True Medicine (Volume 4) (The Other Voice in Early Modern Europe: The Toronto Series) book is in very low demand now as the rank for the book is 5,553,947 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.